Your browser doesn't support javascript.
loading
An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Lekamwasam, S; Adachi, J D; Agnusdei, D; Bilezikian, J; Boonen, S; Borgström, F; Cooper, C; Perez, A Diez; Eastell, R; Hofbauer, L C; Kanis, J A; Langdahl, B L; Lesnyak, O; Lorenc, R; McCloskey, E; Messina, O D; Napoli, N; Obermayer-Pietsch, B; Ralston, S H; Sambrook, P N; Silverman, S; Sosa, M; Stepan, J; Suppan, G; Wahl, D A; Compston, J E.
Afiliação
  • Lekamwasam S; Centre for Metabolic Bone Diseases, Department of Medicine, Faculty of Medicine, Galle, Sri Lanka.
Arch Osteoporos ; 7: 25-30, 2012.
Article em En | MEDLINE | ID: mdl-23225278
ABSTRACT
The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Doenças Reumáticas / Antirreumáticos / Glucocorticoides Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Arch Osteoporos Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Sri Lanka
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Doenças Reumáticas / Antirreumáticos / Glucocorticoides Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Arch Osteoporos Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Sri Lanka